603928.CG
Xingye Shares Clarifies After Two Consecutive Limit-Ups: Phenolic Resin for Photoresist Only in Sample Testing, No Supply Contract Signed
Xingye Shares issued an announcement on unusual stock trading activity, clarifying the photoresist concept that has drawn market attention. The company stated that its phenolic resin for semiconductor photoresist is currently only in the sample testing stage, with a limited number of customers receiving samples. Because customer requirements are stringent, the product is still in the stage of performance and parameter research and development, as well as trial matching. The company said it has not signed any supply contracts, has not yet generated sales revenue, and there is significant uncertainty as to whether the product can ultimately be successfully commercialized. The company also emphasized that its main business has not changed.
603928.CG · Technology · Neutral Company clarified its photoresist phenolic resin is only in sample testing with no supply contracts or revenue, and commercialization is highly uncertain.